Australia’s Top 20 cancer drugs to reach sales of $1 billion by 2018
12-Mar-2010
- Australia
Most read news
Topics
Datamonitor
breast cancer
Avastin
Roche
Herceptin
cancer therapy
oncology
molecular targeted therapies
antihormonal treatments
tumors
toxicity
Therapeutic Goods Administration
Rituxan
metastatic colorectal cancer
MabThera
lung cancer
growth factors
GlaxoSmithKline
gastric cancer
cytotoxic therapies
colorectal cancer
Reissert Compound
Ohira-Bestmann Reagent
Organizations
Datamonitor
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.